1323 Stock Overview
De Rucci Healthy Sleep Co., Ltd. engages in the research and development, production, and sale of healthy sleep systems in China and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 1323 from our risk checks.
De Rucci Healthy Sleep Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥32.05 |
52 Week High | CN¥39.85 |
52 Week Low | CN¥27.37 |
Beta | 0 |
1 Month Change | 3.89% |
3 Month Change | 9.20% |
1 Year Change | -4.27% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -42.83% |
Recent News & Updates
Shareholder Returns
1323 | CN Consumer Durables | CN Market | |
---|---|---|---|
7D | 0.3% | 4.4% | -0.4% |
1Y | -4.3% | 4.6% | -16.2% |
Return vs Industry: 001323 underperformed the CN Consumer Durables industry which returned 4.6% over the past year.
Return vs Market: 001323 exceeded the CN Market which returned -16.2% over the past year.
Price Volatility
1323 volatility | |
---|---|
1323 Average Weekly Movement | 3.9% |
Consumer Durables Industry Average Movement | 9.1% |
Market Average Movement | 8.9% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 001323 has not had significant price volatility in the past 3 months.
Volatility Over Time: 001323's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | 6,041 | Bingkun Wang | www.derucci.com |
De Rucci Healthy Sleep Co., Ltd. engages in the research and development, production, and sale of healthy sleep systems in China and internationally. It offers smart sleep, simple, blue luxury, 0769, 3D, Kaiqi, song Tiya, Kairui, New Nordic, Children, Sleep Aid, DeRUCCI HOME, Home Textiles, Mousse Sousse, Mousse Tonight, and other product series.
De Rucci Healthy Sleep Co., Ltd. Fundamentals Summary
1323 fundamental statistics | |
---|---|
Market cap | CN¥13.02b |
Earnings (TTM) | CN¥800.44m |
Revenue (TTM) | CN¥5.46b |
16.0x
P/E Ratio2.3x
P/S RatioIs 1323 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
1323 income statement (TTM) | |
---|---|
Revenue | CN¥5.46b |
Cost of Revenue | CN¥2.76b |
Gross Profit | CN¥2.70b |
Other Expenses | CN¥1.90b |
Earnings | CN¥800.44m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 27, 2024
Earnings per share (EPS) | 2.00 |
Gross Margin | 49.45% |
Net Profit Margin | 14.65% |
Debt/Equity Ratio | 4.3% |
How did 1323 perform over the long term?
See historical performance and comparison